Measurable Residual Disease in ALL: Proof of the Principle Transforming Care for Patients With Hematologic Malignancies

MRD in ALL Program Image
Take advantage of these resources for using MRD as a tool during management of patients with ALL. Watch a CME/CE/ACPE-certified expert panel discussion or one of several patient-focused short videos, read concise expert commentaries, and download the slideset and clinical resource PDF.
Elias Jabbour, MD

ClinicalThought

New data emphasize the importance of MRD testing in patients with ALL

Elias Jabbour, MD Released: July 27, 2018
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

This activity is supported by educational grants from
Adaptive Biotechnologies
Amgen

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?